Rabphilin-3A as a novel target to reverse α-synuclein-induced synaptic loss in Parkinson's disease.
Ferrari E, Scheggia D, Zianni E, Italia M, Brumana M, Palazzolo L, Parravicini C, Pilotto A, Padovani A, Marcello E, Eberini I, Calabresi P, Diluca M, Gardoni F.
Ferrari E, et al. Among authors: eberini i.
Pharmacol Res. 2022 Sep;183:106375. doi: 10.1016/j.phrs.2022.106375. Epub 2022 Jul 30.
Pharmacol Res. 2022.
PMID: 35918045
Free article.